myGeneticRisk myGeneticRisk Genetic test for risk of common diseases myGeneticRisk is the preventive genetic test that determines the hereditary risk of cardiovascular disease and cancer, the most common diseases worldwide. Knowing the predisposition to these diseases allows the specialist to establish medical management strategies to prevent or detect them in early stages, when treatment is typically more effective. Among the enormous amount of information contained in your DNA, we analyse 162 genes related to clinically relevant actionable diseases. The test includes the most important genes related to hereditary risk of cardiovascular disease and cancer, and complements the analysis with other diseases recommended for study by the ACMG (American College of Medical Genetics and Genomics). Who is it intended for? Any healthy person who is proactive about their healthcare. Amateur and professional athletes who wants to know their risk of cardiovascular disease. People who want to find out about their risk of hereditary cancer. myGeneticRisk analyses the risk of common genetic diseases It enables preventive medicine strategies to be established.It analyses the genetic risk of developing common hereditary diseases.It analyses 162 genes, including the genes recommended by the ACMG (American College of Medical Genetics and Genomics) related to actionable diseases.It is a one-time process and, in the event that a variant is detected, it enables genetically-tailored prevention strategies to be established.If a variant is detected, it enables to screen family members who may be at risk and could benefit from prevention strategies.Includes pre- and post-test genetic counselling consultation to assess suitability, explain results and establish next steps. myGeneticRisk includes: Whole exome sequencing and interpretation of 162 selected genes. Storage of sequencing data that allows subsequent reanalysis.Possibility of extending the study to other genes of interest.Access to the Exome Diagnostic Interpretation Service.Counselling offered by medical geneticists for both the patient and the specialist, if requested.Results report available in 8 weeks. Are you interested in myGeneticRisk but you do not have a prescribing doctor? Our medical professionals can help you. Please click on the button below to learn more. FIND OUT MORE DOWNLOAD PATIENT BROCHURE myGeneticRisk Advantages Genetic testing has significantly reduced the impact of hereditary cancer and heart diseases. Common diseases: The diseases studied are the most common among the population and a significant percentage have a genetic origin. Prevention: Based on the results specific medical management can be established, including prevention strategies, when necessary. Up-to-date results: The team of geneticists analyse the genetic data and ensure that the results are issued based on the most up-to-date scientific knowledge. Detailed report: Report with detailed medical content. Genetic counselling: Differential service of expert genetic counselling in several medical areas, for specialists and patients. Future updates: Veritas offers access to information of interest that may be incorporated in the future. 5-20% Between 5 -20% of cancer cases are of hereditary origin, the percentage varies according to the type of cancer. 30% Approximately 30% of sudden deaths are due to genetic abnormalities related to the structure of the heart muscle or heart rate. 5,4% More than 5% of people present a variant in the genes recommended by the ACMG. Are you interested in offering myGeneticRisk? If you are a healthcare provider and you are interested, please contact us to find out how we can collaborate. CONTACT DOWNLOAD MEDICAL BROCHURE Advice to the specialist Veritas offers you its team of professionals with whom you can arrange a genetic counseling consultation in person or online, to answer your questions and analyze your specific case. GENETIC CONSULTING
